Clincosm LogoSign in Get a demo

Glioblastoma

Showing NaN - NaN of 75
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma Trial in United States (Temozolomide, Neratinib, QBS10072S)

Active, not recruiting
  • Glioblastoma
  • Birmingham, Alabama
  • +11 more
Aug 15, 2022

Glioblastoma Trial in United States (biological, radiation, drug)

Active, not recruiting
  • Glioblastoma
  • INO-5401
  • +4 more
  • Duarte, California
  • +20 more
Aug 8, 2022

Glioblastoma, Esophageal Cancer, Radiotherapy Trial in Boston (MRI IMAGING)

Recruiting
  • Glioblastoma
  • +7 more
  • MRI IMAGING
  • Boston, Massachusetts
  • +1 more
Aug 8, 2022

Glioblastoma, Recurrent Glioblastoma Trial in Boston (Pembrolizumab, Olaparib, Temozolomide)

Not yet recruiting
  • Glioblastoma
  • Recurrent Glioblastoma
  • Boston, Massachusetts
  • +2 more
Jul 14, 2022

Glioblastoma Multiforme, Glioblastoma Trial in United States (biological, procedure, drug)

Not yet recruiting
  • Glioblastoma Multiforme
  • Glioblastoma
  • IGV-001 Cell Immunotherapy
  • +3 more
  • Newark, Delaware
  • +22 more
Jun 24, 2022

Glioblastoma Trial in Boston (radiation, biological, drug)

Recruiting
  • Glioblastoma
  • Radiation Therapy
  • +3 more
  • Boston, Massachusetts
  • +1 more
May 31, 2022

Glioblastoma Multiforme, Glioblastoma, GBM Trial in Worldwide (Dendritic cell immunotherapy)

Active, not recruiting
  • Glioblastoma Multiforme
  • +6 more
  • Dendritic cell immunotherapy
  • Birmingham, Alabama
  • +85 more
May 12, 2022

Glioblastoma, Diffuse Midline Glioma, H3 K27M Glioma Trial in United States (ONC201)

Active, not recruiting
  • Glioblastoma
  • +5 more
  • Los Angeles, California
  • +4 more
Apr 8, 2022

Brain Tumors by Advanced MRI

Completed
  • Glioblastoma
  • Avastin
  • +5 more
  • Boston, Massachusetts
    Massachusetts general Hospital
Apr 6, 2022

Glioblastoma Trial in Worldwide (DSP-7888 Dosing Emulsion, Bevacizumab)

Active, not recruiting
  • Glioblastoma
  • Birmingham, Alabama
  • +60 more
Apr 4, 2022

Cytochrome C Oxidase Activity in Newly Diagnosed Glioblastoma

Active, not recruiting
  • Glioblastoma
    • Birmingham, Alabama
    • +18 more
    Mar 7, 2022

    Glioblastoma Trial in Boston (Pembrolizumab, Abemaciclib)

    Withdrawn
    • Glioblastoma
    • Boston, Massachusetts
    • +1 more
    Dec 13, 2021

    Glioblastoma, Recurrent Glioblastoma, Supratentorial Glioblastoma Trial in United States (lerapolturev, pembrolizumab)

    Active, not recruiting
    • Glioblastoma
    • +3 more
    • lerapolturev
    • pembrolizumab
    • San Francisco, California
    • +9 more
    Nov 30, 2021

    Glioblastoma Trial in United States (Ad-RTS-hIL-12, Veledimex, Cemiplimab-Rwlc)

    Completed
    • Glioblastoma
    • Ad-RTS-hIL-12
    • +2 more
    • Los Angeles, California
    • +6 more
    Nov 3, 2021

    Glioblastoma Trial in Boston (Temozolomide, Bavituximab, Radiation)

    Active, not recruiting
    • Glioblastoma
    • Boston, Massachusetts
    • +1 more
    Oct 27, 2021

    Glioblastoma Trial in United States (Ad-RTS-hIL-12, veledimex, Nivolumab)

    Completed
    • Glioblastoma
    • Ad-RTS-hIL-12
    • +2 more
    • Chicago, Illinois
    • +3 more
    Oct 1, 2021

    Advanced Malignancy, Advanced Solid Tumors, Cancer Trial in France, Netherlands, United States (AMG 232)

    Completed
    • Advanced Malignancy
    • +7 more
    • AMG 232
    • Santa Monica, California
    • +13 more
    Aug 30, 2021

    MicroRNA-10b in Patients With Gliomas

    Recruiting
    • Astrocytoma
    • +8 more
      • Boston, Massachusetts
      • +3 more
      May 30, 2021

      Glioblastoma Trial in Boston, Cleveland (Nivolumab, Standard Dose Bevacizumab, Low Dose Bevacizumab)

      Active, not recruiting
      • Glioblastoma
      • Boston, Massachusetts
      • +1 more
      May 21, 2021

      Grade II Glioma, Grade III Glioma, Grade IV Glioma Trial in Boston (Microdevice)

      Recruiting
      • Grade II Glioma
      • +7 more
      • Microdevice
      • Boston, Massachusetts
        Brigham and Women's Hospital
      Feb 22, 2021

      Glioblastoma Trial in United States (Pembrolizumab, Bevacizumab)

      Completed
      Has Results
      • Glioblastoma
      • Los Angeles, California
      • +7 more
      Nov 30, 2020

      Glioblastoma Trial in Worldwide (BKM120 + temozolomide, BKM120 +temozolomide with/without radiotherapy)

      Completed
      • Glioblastoma
      • BKM120 + temozolomide
      • BKM120 +temozolomide with/without radiotherapy
      • Fayetteville, Arkansas
      • +7 more
      Dec 6, 2020

      Malignant Melanoma, Medullary Thyroid Cancer, Glioblastoma Trial in United States (Rovalpituzumab tesirine, Dexamethasone)

      Terminated
      Has Results
      • Malignant Melanoma
      • +7 more
      • Gilbert, Arizona
      • +29 more
      Sep 21, 2020

      B-cell Malignancies, Colorectal Cancer (CRC), Head Neck Cancer Trial in United Kingdom, United States (Nivolumab (Phase 1),

      Completed
      • B-cell Malignancies
      • +7 more
      • Nivolumab (Phase 1)
      • +4 more
      • Birmingham, Alabama
      • +23 more
      Aug 26, 2020

      Glioblastoma Trial in Worldwide (Depatuxizumab mafodotin, Temozolomide, Lomustine)

      Completed
      Has Results
      • Glioblastoma
      • Depatuxizumab mafodotin
      • +2 more
      • Palo Alto, California
      • +101 more
      May 8, 2020